Karista is a venture capital firm established in 2001 and located in Paris, France. The firm specializes in incubation and early-stage investments, focusing on a diverse range of sectors including healthcare, information and communication technology, nanotechnology, and clean technology. It actively invests in startups engaged in biotechnology, medical equipment, digital technologies, deep tech, and newspace, among other areas. Karista typically directs investments ranging from €0.5 million to €5 million in companies with revenues up to €4 million. The firm primarily operates within France, particularly in the Ile-de-France region and Paris, and has supported over 90 companies over the past two decades, emphasizing partnerships with entrepreneurs who share a common vision.
SamanTree Medical SA is a Swiss company specializing in the development of innovative medical microscopy devices aimed at enhancing cancer treatment and surgical outcomes. Founded in 2014 and based in Ecublens, the company focuses on micro-optics-based digital microscopy systems that provide an extensive field of view for various applications, including research, diagnostics, and surgery. Its flagship product, a surgical digital microscope, enables real-time visualization of cellular structures within living tissue, facilitating precise assessment of tumor margins. This technology allows surgeons to achieve full margin control and make informed decisions during procedures, ultimately improving resection accuracy, reducing re-operation rates, and decreasing overall procedure costs. By enabling immediate visualization of cancerous cells during surgery, SamanTree Medical's devices significantly enhance patient care and outcomes in cancer surgery.
BforeAI
Series B in 2024
BforeAI specializes in predictive attack intelligence and Digital Risk Protection Services (DRPS). Utilizing its innovative PreCrime™ technology powered by behavioral AI, the company aims to shift cyber defense from a reactive to a proactive stance. BforeAI's offerings include automated threat intelligence, brand protection, adversary disruption, and domain takedowns. The firm provides AI-predicted lists of malicious domains, enabling organizations to predict, monitor, and mitigate cyber threats before they materialize. Recognized by Gartner in multiple reports and awarded accolades such as the FinTech Innovation Lab New York, BforeAI is committed to delivering rapid and precise automated defenses against online fraud, thereby enhancing the security posture of its clients.
Brightflow
Series A in 2024
Brightflow operates as a medical device startup.
Deemea
Seed Round in 2024
Deemea is a developer of a digital medical assistance platform tailored for clinical research and the analysis of real-life data. The company's AI-driven platform assists clinical research operators by streamlining the imaging data journey, enhancing efficiency and reliability. It utilizes artificial intelligence to identify suitable databases, expedites contractual and regulatory processes, and simplifies external model validation. Additionally, Deemea's platform optimizes responses to internal and external requests while valorizing real-world data and clinical studies. Through these capabilities, Deemea supports clients in accelerating the development and deployment of innovative projects that leverage AI tools specific to the valorization of medical data.
BforeAI
Series A in 2024
BforeAI specializes in predictive attack intelligence and Digital Risk Protection Services (DRPS). Utilizing its innovative PreCrime™ technology powered by behavioral AI, the company aims to shift cyber defense from a reactive to a proactive stance. BforeAI's offerings include automated threat intelligence, brand protection, adversary disruption, and domain takedowns. The firm provides AI-predicted lists of malicious domains, enabling organizations to predict, monitor, and mitigate cyber threats before they materialize. Recognized by Gartner in multiple reports and awarded accolades such as the FinTech Innovation Lab New York, BforeAI is committed to delivering rapid and precise automated defenses against online fraud, thereby enhancing the security posture of its clients.
10Lines
Series A in 2024
10Lines is focused on creating autonomous robots that enhance the efficiency of pavement marking, specifically for parking lot layouts. By developing innovative technological solutions, the company aims to improve productivity for striping businesses while minimizing their environmental impact. These robots provide a sustainable method for striping, allowing firms to complete their tasks more quickly and effectively. As a result, striping companies can significantly increase their output without needing to expand their workforce, leading to cost savings and greater operational efficiency.
Heex Technologies
Seed Round in 2024
Heex Technologies offers a data management platform aimed at assisting engineering teams in transitioning from Big Data to Smart Data. The platform automates data pipelines and workflows, allowing companies to extract relevant data efficiently, either at the edge or in the cloud. By focusing on providing precise information, Heex Technologies helps organizations improve productivity, optimize costs, and enhance resource management. This approach addresses the challenges faced by businesses in adapting to the evolving demands of artificial intelligence, where the need for specific and actionable data has become increasingly critical.
Kranus Health
Series A in 2023
Kranus Health is a prominent global provider of virtual care in the field of Urology, specializing in clinically validated therapies for various conditions, including those related to Andrology and Uro-Oncology. The company operates a digital health platform designed to assist men in overcoming issues such as erectile dysfunction and nausea. Through this platform, Kranus Health offers a comprehensive range of services, including pelvic floor training, cardiovascular training, mental health support, medical supervision, and preventive therapies. This approach empowers patients to manage their health conditions from the comfort of their homes, promoting healthier and longer lives.
constellr
Seed Round in 2023
Constellr is a company that develops advanced imaging technology for the agriculture sector, focusing on evaluating soil health, vegetation, and industrial monitoring through proprietary space infrastructure. By measuring critical factors such as water, temperature, and carbon, Constellr provides essential data that supports high-precision smart farming services, thereby contributing to global food security. The company addresses climate change by offering accountability and monitoring solutions across multiple markets. Its technology underpins various remote sensing products, including models for evapotranspiration, water stress, and crop yield prediction, enabling farmers, agronomists, agricultural companies, and infrastructure managers to gain precise insights and make informed decisions.
Look Up Space
Seed Round in 2023
Look Up Space specializes in providing high-quality space safety and security data and services designed to assist organizations in effectively managing space-related risks. The company utilizes a dedicated, sovereign sensor network combined with advanced data processing capabilities to deliver real-time information. This approach enables businesses to access critical data that supports their growth while simplifying the complexities associated with space safety and security.
Beev
Seed Round in 2023
Beev is a mobility platform based in Paris, France, founded in 2020, that provides electric vehicle solutions for both businesses and households. The company facilitates the decarbonization of mobility by offering a comprehensive service that includes the purchase of electric vehicles and the installation of charging stations in various locations, such as homes and public spaces. Beev's platform emphasizes user convenience through features like online signatures, price transparency, and flexible payment options, enabling customers to save time and money while making the transition to electric mobility.
Exotrail
Series B in 2023
Exotrail specializes in electric propulsion solutions for small satellites, providing advanced Hall Effect Thrusters designed to enhance the agility and efficiency of satellite constellations. Founded in 2015 by David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz in Palaiseau, Ile-de-France, the company aims to revolutionize sectors such as telecommunications, earth observation, and space science. Exotrail's technology allows for greater flexibility in satellite deployment, enabling clients to access new orbits, extend operational lifespans, and optimize service performance. The company's focus on small satellite propulsion contributes to reducing space pollution while facilitating more effective satellite operations in orbit.
Heex Technologies
Pre Seed Round in 2022
Heex Technologies offers a data management platform aimed at assisting engineering teams in transitioning from Big Data to Smart Data. The platform automates data pipelines and workflows, allowing companies to extract relevant data efficiently, either at the edge or in the cloud. By focusing on providing precise information, Heex Technologies helps organizations improve productivity, optimize costs, and enhance resource management. This approach addresses the challenges faced by businesses in adapting to the evolving demands of artificial intelligence, where the need for specific and actionable data has become increasingly critical.
BforeAI
Series A in 2022
BforeAI specializes in predictive attack intelligence and Digital Risk Protection Services (DRPS). Utilizing its innovative PreCrime™ technology powered by behavioral AI, the company aims to shift cyber defense from a reactive to a proactive stance. BforeAI's offerings include automated threat intelligence, brand protection, adversary disruption, and domain takedowns. The firm provides AI-predicted lists of malicious domains, enabling organizations to predict, monitor, and mitigate cyber threats before they materialize. Recognized by Gartner in multiple reports and awarded accolades such as the FinTech Innovation Lab New York, BforeAI is committed to delivering rapid and precise automated defenses against online fraud, thereby enhancing the security posture of its clients.
CYSEC
Seed Round in 2022
CYSEC is a startup focused on advancing Confidential Computing solutions that protect data throughout its lifecycle—at rest, in motion, and in use. The company has developed a cloud-based data security software that operates through a physical enterprise-grade server appliance, ensuring the integrity and confidentiality of data stored in the cloud. Their flagship product, the ARCA solution, is gaining popularity in the market for its effectiveness in safeguarding assets. By enabling businesses to innovate in the realm of confidential computing, CYSEC aims to provide robust cybersecurity systems applicable across various sectors.
Incepto
Venture Round in 2022
Incepto is a developer of an artificial intelligence-based medical imaging platform aimed at addressing the challenges faced by healthcare professionals overwhelmed by patient volume and medical images. The platform offers advanced tools for interpreting computed tomography scans, chest x-rays, and detecting conditions such as fractures and bowel occlusions. Incepto specializes in creating AI-driven applications for mammogram screening and automated management of pulmonary nodules, facilitating enhanced patient care. The company's mission is to empower healthcare professionals by involving them in the AI production process through co-creation projects, ensuring that the tools developed meet the real needs of physicians and data scientists.
TRiCares
Series C in 2022
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.
Ludocare
Seed Round in 2022
Ludocare focuses on developing therapeutic robots that assist patients with chronic diseases and their families. The company's innovative devices are designed to complement traditional drug treatments by providing personalized support that enhances treatment efficiency. By empowering patients, especially children, Ludocare aims to improve therapeutic compliance both quantitatively and qualitatively. This approach facilitates better disease management and helps stabilize essential treatments, ultimately contributing to improved autonomy and quality of life for patients and their families.
Vestack
Series A in 2022
Vestack is a PropTech company specializing in the design and manufacture of low-carbon buildings constructed from bio-sourced materials. By utilizing a modular construction system, Vestack offers flexible solutions for various applications, including residential and public buildings, while accommodating diverse architectural styles and land plot constraints. The company integrates proprietary software and hardware technology to promote the construction of healthy and sustainable structures, ensuring rapid production and cost-effectiveness for project developers. Acting as a general contractor, Vestack collaborates with real estate developers to deliver innovative, environmentally friendly building solutions.
Leanspace
Seed Round in 2022
Leanspace is a developer of an integrated cloud platform tailored for public and private space organizations, aimed at streamlining space missions. The platform combines cloud technologies with space engineering concepts, offering a range of generic functions as services via APIs. This approach allows organizations to build their systems in-house while only developing the specific functionalities they require, thereby reducing both time and costs. By providing an innovative and collaborative framework, Leanspace enhances the agility of space organizations, enabling them to maintain control over their tools and improve their competitiveness in an increasingly complex industry.
Kranus Health
Series A in 2022
Kranus Health is a prominent global provider of virtual care in the field of Urology, specializing in clinically validated therapies for various conditions, including those related to Andrology and Uro-Oncology. The company operates a digital health platform designed to assist men in overcoming issues such as erectile dysfunction and nausea. Through this platform, Kranus Health offers a comprehensive range of services, including pelvic floor training, cardiovascular training, mental health support, medical supervision, and preventive therapies. This approach empowers patients to manage their health conditions from the comfort of their homes, promoting healthier and longer lives.
Miratlas
Seed Round in 2022
Miratlas specializes in developing integrated sky monitoring devices that enhance the understanding of climate change and atmospheric conditions. The company focuses on providing continuous and real-time atmospheric measurements, which are essential for improving optical communication between Earth and space. Their instrumentation is designed to monitor various factors, including cloud cover, turbulence, and absorption, thereby enabling businesses to access accurate weather and atmospheric conditions for nowcasting. By unveiling the effects of atmospheric turbulence, Miratlas aims to ensure reliable communication technologies and improve air quality predictions in urban environments.
Implicity
Series A in 2022
Implicity is a developer of a remote monitoring platform that specializes in the smart monitoring of patients with connected cardiac devices, such as pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on individual medical contexts. This capability allows cardiologists and healthcare professionals to automate the monitoring process, enabling them to effectively oversee patient health while consolidating information on a single platform. By streamlining remote monitoring, Implicity aims to enhance the quality of care provided to patients with cardiac implants.
Humanlinker
Seed Round in 2022
Humanlinker is a technology company that specializes in AI-guided solutions for revenue generation teams. Their platform leverages artificial intelligence algorithms to provide account-based selling strategies, identify strategic accounts ready for assignment, and track relevant data to enhance sales interactions. The company aims to help businesses improve their sales processes by utilizing cutting-edge technology.
Sitowie
Seed Round in 2022
Sitowie is a company that specializes in developing software as a service (SaaS) technology aimed at understanding and managing the degradation of buildings. Utilizing artificial intelligence and machine learning, Sitowie's platform assists clients in anticipating risks associated with the aging of structures. The tools provided by the company not only enhance the sustainability of buildings but also contribute to cost reduction and facilitate effective arbitration processes. By focusing on the preservation and sustainability of heritage properties, Sitowie aims to support clients in making informed decisions regarding building maintenance and management.
i-Lunch
Series A in 2021
i-Lunch offers corporate catering services. I-Lunch provides businesses with adaptable, high-demand, and customized solutions. I-online Lunch's ordering platform offers useful and delectable recipes that are prepared in returnable glass containers and developed jointly by the company's nutritionists and chefs.
MoveUP
Seed Round in 2021
MoveUP is a company focused on developing and commercializing digital therapeutics solutions designed to enhance healthcare delivery. Its innovative platform features a closed-loop system that ensures high compliance and improved outcomes for patients. By continuously collecting data, the platform personalizes treatment plans, significantly enhancing patient satisfaction. MoveUP's initial product targets orthopedic patients recovering from joint surgery, providing a user-friendly medical-grade mobile application that supports faster recovery. The company holds CE medical device and ISO 13485 certifications, underscoring its commitment to quality and regulatory standards in the healthcare sector.
Vestack
Series A in 2021
Vestack is a PropTech company specializing in the design and manufacture of low-carbon buildings constructed from bio-sourced materials. By utilizing a modular construction system, Vestack offers flexible solutions for various applications, including residential and public buildings, while accommodating diverse architectural styles and land plot constraints. The company integrates proprietary software and hardware technology to promote the construction of healthy and sustainable structures, ensuring rapid production and cost-effectiveness for project developers. Acting as a general contractor, Vestack collaborates with real estate developers to deliver innovative, environmentally friendly building solutions.
Ramdam
Seed Round in 2020
Ramdam is a developer of a digital assistant application focused on simplifying the car buying process. The application utilizes conversational artificial intelligence to facilitate online car searches, making the experience engaging and user-friendly through an interactive swiper interface. By connecting car dealers with potential buyers, Ramdam allows dealers to showcase their inventory effectively to a targeted audience, enhancing community engagement and user interest in their listings. This innovative approach aims to streamline the content creation process for users while promoting an enjoyable car shopping experience.
Exotrail
Series A in 2020
Exotrail specializes in electric propulsion solutions for small satellites, providing advanced Hall Effect Thrusters designed to enhance the agility and efficiency of satellite constellations. Founded in 2015 by David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz in Palaiseau, Ile-de-France, the company aims to revolutionize sectors such as telecommunications, earth observation, and space science. Exotrail's technology allows for greater flexibility in satellite deployment, enabling clients to access new orbits, extend operational lifespans, and optimize service performance. The company's focus on small satellite propulsion contributes to reducing space pollution while facilitating more effective satellite operations in orbit.
Eyevensys
Series B in 2020
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
Tallano
Series A in 2019
Tallano Technologie is a French company founded in 2012, based in Boulogne-Billancourt, that specializes in reducing particle emissions from vehicle braking systems. The company has developed a proprietary technology known as tamic, which effectively captures particles at the source through suction. This innovative particle collector is designed to be installed between the brake disc and pad in both private cars and public transport vehicles. Tallano Technologie positions itself as a leader in the field of particle emission reduction, addressing environmental concerns associated with vehicular braking systems.
UpFactor
Seed Round in 2019
UpFactor is an independent consultancy based in Paris, France, specializing in site analysis and large-scale detection of aerial land potential. Founded in 2017, the company utilizes a geographic information system that aggregates essential data for assessing building possibilities, including addresses, street widths, building heights, zoning regulations, solar land registers, and protected areas. UpFactor provides building heightening services that enable property owners to increase the number of floors on existing structures. This approach allows businesses to expand their usable space within already developed areas, promoting sustainable development while minimizing land use. The firm combines expertise in architecture, engineering, and law to support real estate and construction sectors effectively.
TISSIUM
Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
Incepto
Seed Round in 2019
Incepto is a developer of an artificial intelligence-based medical imaging platform aimed at addressing the challenges faced by healthcare professionals overwhelmed by patient volume and medical images. The platform offers advanced tools for interpreting computed tomography scans, chest x-rays, and detecting conditions such as fractures and bowel occlusions. Incepto specializes in creating AI-driven applications for mammogram screening and automated management of pulmonary nodules, facilitating enhanced patient care. The company's mission is to empower healthcare professionals by involving them in the AI production process through co-creation projects, ensuring that the tools developed meet the real needs of physicians and data scientists.
cozycozy.com
Venture Round in 2019
Cozycozy is a search engine that allows travelers to compare the full range of available accommodation options, ensuring that they find the place that best meets their needs and always at the best price. It allows users to search for all available accommodation options in one place, including hotels, apartments, houses, youth hostels, lodges, boats, tree houses, cottages, cabins, and more.
Algaia
Acquisition in 2019
Algaia is engaged in the development, production, and commercialization of natural extracts primarily derived from seaweed. The company provides a diverse array of sustainable products and solutions tailored for the agro-nutrition, personal care, and pharmaceutical industries. Following its acquisition of Alganact SA, Algaia has expanded its offerings to include a service division that assists clients in understanding the potential of their seaweed biomass and characterizing their extracts. By utilizing eco-friendly proprietary biotechnologies, Algaia produces natural extracts that serve as stabilizing and thickening agents, enhancing water retention for various applications in agro-nutrition, personal care, and nutraceutical sectors.
Implicity
Seed Round in 2019
Implicity is a developer of a remote monitoring platform that specializes in the smart monitoring of patients with connected cardiac devices, such as pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on individual medical contexts. This capability allows cardiologists and healthcare professionals to automate the monitoring process, enabling them to effectively oversee patient health while consolidating information on a single platform. By streamlining remote monitoring, Implicity aims to enhance the quality of care provided to patients with cardiac implants.
Misakey
Seed Round in 2019
Misakey SAS is a company based in Paris, France, that specializes in developing a personal data protection platform aimed at managing digital identities. Founded in 2018, Misakey's platform enables users to access and control their personal data across various social media and online platforms. It allows individuals to recover their data, request updates, and initiate deletions or restrictions, thereby empowering them to reclaim control over their personal information. Additionally, the platform facilitates collaboration for webmasters to integrate applications and create compliant websites, enhancing overall data security and management.
Admo.tv
Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.
Acticor Biotech
Series B in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.
Acticor Biotech
Series B in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.
Wisebatt
Seed Round in 2018
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.
Wisebatt
Seed Round in 2018
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.
TRiCares
Series B in 2018
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.
Serious Factory
Series A in 2018
Serious Factory is a Paris-based company founded in 2007 that specializes in developing innovative training and sales support simulators. The company's primary offering is the Virtual Training Suite, a Software-as-a-Service solution that enhances traditional learning processes across various industries, including aerospace, automotive, banking, construction, energy, luxury, retail, medical, and telecommunications. Serious Factory leverages expertise in instructional engineering and gamification to create effective training programs that encompass digital learning modules, serious games, blended learning, and practical simulations. Their technology enables businesses to design, distribute, and regularly update educational content while also monitoring skill development. Serious Factory operates through a network of partner resellers across Europe, Asia, and North America.
Appscho
Seed Round in 2018
AppScho, SAS, established in 2014 and headquartered in Paris, France, specializes in mobile application software for higher education. Its application centralizes essential information for students and educational institutions, providing access to schedules, grades, school events, and employment opportunities. The app enhances student engagement by offering features such as course previews, classroom details, and notifications for schedule changes. Additionally, it facilitates communication between institutions and students, allowing educators to monitor student engagement and analyze performance. By streamlining campus content and services, AppScho aims to improve the overall academic experience and support students in managing their studies effectively.
Pherecydes Pharma
Series B in 2018
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, established in 2006. It specializes in the research and development of lytic bacteriophages, which are natural predators of bacteria, for therapeutic and diagnostic applications, particularly in addressing antibiotic resistance. The company has developed several banks of bacteriophages, including a collection targeting Escherichia coli. Pherecydes Pharma is engaged in innovative approaches to personalized phage therapy, aiming to treat bacterial infections by launching multicenter European trials, such as those evaluating phage therapy for infected burn wounds. This therapeutic strategy allows for the detection and treatment of a wide range of bacterial infections, including multi-resistant and emergent strains, without affecting human cells.
Acticor Biotech
Series A in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.
Precogs
Venture Round in 2017
Precogs is a company based in Paris, France, founded in 2011, that specializes in business analytics solutions tailored for EMS-ODM-OEM sectors. The company offers a range of services, including supply risk management, enterprise resource planning (ERP), and procurement monitoring. Its key products feature CogWatch, a predictive tool leveraging big data, and Cog Margin, a platform designed for component pricing. Precogs focuses on providing real-time sourcing of electronic components, ensuring that clients receive competitive pricing for their needs.
PayinTech
Venture Round in 2017
PayinTech, founded in 2010 by Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji, specializes in cashless payment solutions utilizing IoT technology. Initially developed for a student bar, the company expanded its offerings to include electronic wristbands and wireless payment terminals, enabling efficient transaction management at large events. Notably, PayinTech powered Europe's first fully cashless festival in 2012, serving 14,000 attendees. With significant funding raised in 2015 and 2017, the company has invested in research and development, allowing it to diversify its services across various private payment markets. PayinTech now operates in 16 countries, providing solutions to resorts, amusement parks, stadiums, and other organizations, enhancing their revenue while improving user experience and optimizing management costs. The company's goal remains to simplify transactional systems for corporate clients in the entertainment and tourism sectors.
Acticor Biotech
Venture Round in 2017
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.
Ugloo
Venture Round in 2017
Ugloo provides a robust data storage solution designed to enhance data security and management. The company offers a secondary storage platform that allows businesses to upgrade their existing infrastructure by creating virtual racks. This innovative approach enables efficient use of available space, eliminating the need for additional investments in physical storage while ensuring complete governance over data. Ugloo's solution facilitates the secure backup, sharing, and transmission of large files across various platforms, making it an essential tool for organizations seeking to protect vital information.
Nexdot
Venture Round in 2016
Nexdot specializes in the synthesis, production, and application of advanced semiconductor nanocrystals known as Quantum Dots (QDs), with a focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Founded as a spin-off from a leading academic laboratory in Paris, Nexdot leverages over a decade of research in nanomaterials to create proprietary materials with controlled shape and composition. These innovations are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is developing quantum pearl encapsulation technology to enhance the integration of quantum plates into existing production processes, thereby ensuring compliance with environmental regulations. The company is comprised of a dynamic team of skilled scientists and seasoned executives, dedicated to advancing innovation in the field of nanotechnology.
Restlet
Convertible Note in 2016
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.
TRiCares
Seed Round in 2016
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.
Linkfluence
Series C in 2016
Linkfluence is a social media intelligence company that focuses on analyzing online conversations to create business opportunities for brands. Its flagship product, the Radarly Product Suite, is a user-friendly, multilingual SaaS tool designed for monitoring and measuring social media interactions. This platform collects relevant conversations about brands, providing actionable insights that can be utilized across various organizational functions. Linkfluence's solutions address needs such as reputation management, influencer engagement, community management, crisis detection, and trend analysis. The company has successfully assisted over 200 prominent brands in Europe to enhance their social media strategies, leveraging data to optimize brand performance and inform decision-making.
NAVYA
Series B in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.
Stootie
Series A in 2016
Stootie is a mobile classifieds platform that focuses on facilitating peer-to-peer transactions in real time, primarily within local communities. It serves as a convenient tool for users to quickly find and offer various items or services, catering to immediate needs, such as locating a phone charger while at a café. Available on both iOS and Android, Stootie has established itself as a leading app for peer-to-peer services in France. In addition to general classifieds, the platform also offers information, advice, and tips related to living spaces, DIY projects, gardening, and home decoration, making it a versatile resource for users seeking assistance in various areas of everyday life.
Playtem
Venture Round in 2016
Playtem is a video game monetization platform that aims to bridge the gap between gamers and their favorite brands through innovative in-game native advertising formats. The company focuses on creating emotional connections between players and brands, facilitating daily engagement across web and mobile platforms. By prioritizing impactful advertising that enhances user experience, Playtem seeks to revolutionize the future of advertising in the gaming industry. The team, comprised of passionate entrepreneurs, is dedicated to developing solutions that benefit both brands and gamers alike.
Stereolabs
Venture Round in 2016
Stereolabs Inc. specializes in developing 3D depth sensing technology aimed at enhancing autonomous robotics and augmented reality applications. Founded in 2006 and headquartered in San Francisco, California, with an additional office in Sheung Wan, Hong Kong, the company offers the ZED Stereo Camera, which utilizes passive stereo vision for depth perception. This technology enables machines to understand and interact with their environments in a manner similar to human vision. Stereolabs is also known for Linq, a mixed reality headset that allows users to engage in interactive gaming experiences by merging real and virtual worlds. The ZED camera has gained widespread adoption among developers and is increasingly utilized by major gaming companies for mixed-reality capture in virtual and augmented reality games.
Nexdot
Venture Round in 2016
Nexdot specializes in the synthesis, production, and application of advanced semiconductor nanocrystals known as Quantum Dots (QDs), with a focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Founded as a spin-off from a leading academic laboratory in Paris, Nexdot leverages over a decade of research in nanomaterials to create proprietary materials with controlled shape and composition. These innovations are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is developing quantum pearl encapsulation technology to enhance the integration of quantum plates into existing production processes, thereby ensuring compliance with environmental regulations. The company is comprised of a dynamic team of skilled scientists and seasoned executives, dedicated to advancing innovation in the field of nanotechnology.
Comiteo
Venture Round in 2016
Comitéo, established in 2008, specializes in providing innovative services tailored for works councils through a business productivity software platform. The company focuses on simplifying daily management and enhancing communication within organizations. Its web platform and mobile application are highly configurable, enabling access to technology, culture, recreation, and management tools. Comitéo's software not only facilitates effective communication but also offers employees exceptional promotions from various brands, thereby contributing to employee satisfaction. Additionally, the platform assists clients in managing accounting and budgeting for works councils, ultimately supporting both employee well-being and organizational growth.
Restlet
Convertible Note in 2016
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.
Sevenhugs
Seed Round in 2016
Sevenhugs Inc. specializes in ultra-wideband systems for indoor positioning and orientation tracking, providing innovative solutions for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which serves as a universal remote control for televisions and smart home devices. This product simplifies the smart home experience by allowing users to control various devices—such as lights and music—through a single adaptive interface. Additionally, Sevenhugs offers features like secure localization, data fusion, and a low-power MAC protocol, enhancing its capabilities in access and security as well as location tracking. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.
BnbSitter
Series A in 2016
Bnbsitter is a Paris-based company established in 2013 that specializes in concierge rental services for vacation hosts. It provides a user-friendly online platform that allows hosts to easily book essential services for their guests, such as check-in/check-out assistance and rental cleaning, all within a matter of minutes. Bnbsitter caters to hosts who may be busy, traveling, or otherwise unable to personally welcome their guests, ensuring that visitors receive a warm greeting upon arrival. The company also offers additional services related to property management, including maintenance and inventory management, streamlining the rental experience for both hosts and guests. As of January 2020, Bnbsitter operates as a subsidiary of checkmyguest.
TISSIUM
Series A in 2016
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
Melusyn
Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.
NAVYA
Venture Round in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.
Restlet
Convertible Note in 2015
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.
MOPeasy
Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.
NAVYA
Seed Round in 2015
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.
Mitricares
Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.
SetKeeper
Venture Round in 2015
SetKeeper develops an application platform designed to streamline the physical production process for audiovisual projects, including films, television shows, and broadcasts. The platform offers features such as document watermarking and distribution, script sides, and an electronic signature service, all aimed at facilitating operational and technical management. By leveraging innovative technologies, SetKeeper enhances the production landscape, allowing clients to efficiently coordinate their projects and optimize schedules while ensuring the security and integrity of their materials.
Aterovax
Seed Round in 2015
Aterovax is an in vitro diagnostic company focused on developing innovative solutions for the prediction, diagnosis, and prevention of cardiovascular disease. With a unique understanding of atherosclerosis, Aterovax creates diagnostic tests that assess the level of atherosclerotic plaque development in patients. These tests aim to provide insights into cardiovascular risk, enabling more effective management and intervention strategies for individuals at risk of cardiovascular conditions.
TRiCares
Seed Round in 2015
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.
Actvt
Seed Round in 2015
Actvt Inc. specializes in innovative video editing technology aimed at transforming long videos into engaging short-form content. The company offers a product portfolio that includes Activity, a user-friendly app available on iOS and Android, which assists users in selecting highlights from their footage to automatically generate concise edits. Additionally, Actvt provides Showdown.cc, an in-game replay plugin designed for game developers, allowing players to create, share, and explore gameplay videos. Through these offerings, Actvt seeks to enhance the social video experience by making video creation more accessible and enjoyable.
Prestodiag
Series A in 2015
Prestodiag specializes in the development, manufacturing, and sale of innovative solutions for the rapid detection of pathogenic bacteria. Utilizing advanced Surface Plasmon Resonance imaging technology, the company offers analytical solutions that can identify harmful bacteria such as Salmonella, Listeria, and E. coli within hours, significantly reducing the time required for results compared to traditional methods. Prestodiag primarily serves the food safety sector but also addresses medical and environmental applications. By enabling the early detection of multiple pathogens in complex samples, their systems assist businesses in enhancing the shelf life of products and ensuring safety in food and healthcare environments.
Melusyn
Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.
Eyevensys
Seed Round in 2015
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.
RED Technologies
Seed Round in 2015
RED Technologies specializes in spectrum sharing technologies aimed at addressing the growing demand for accessible and affordable 5G services. The company develops cloud-based solutions that facilitate dynamic spectrum access for private 5G networks, allowing operators to modernize their communication infrastructures effectively. RED’s innovative spectrum access system operates within a three-tier hierarchy, enabling clients to implement proper sharing and protection for users in a multi-tiered spectrum sharing environment. Additionally, RED Technologies is engaged in regulatory developments and standardization efforts to further enhance the accessibility of 5G services.
OpenOcean
Seed Round in 2015
OpenOcean is a venture capital firm established in 2008, with offices in Helsinki and London. It specializes in early-stage investments, particularly targeting Series A funding for technology companies within the data economy across Europe, with a focus on sectors such as B2B platforms, cybersecurity, fintech, artificial intelligence, and cloud technology. The firm is driven by three core investment theses: Automation, Data Infrastructure, and the Future of Software Development, with initial average investments around €5 million. The founding team includes key figures behind MySQL and MariaDB, providing OpenOcean with a strong technical background that enables them to identify and invest in innovative startups with scalable solutions. By leveraging their expertise in technology and software, OpenOcean aims to support the growth of transformative digital platforms and services.
English Attack
Series A in 2015
English Attack is a Web 2.0, entertainment-driven English language learning Entertainment Learning was created to bring leverage the power of digital entertainment to transform the way people learn. Its flagship service, English Attack! (www.english-attack.com) creates true innovation in the $35 billion market for English language learning via a 100% entertainment-driven approach to helping learners increase and enhance their exposure to, and use of, the language. It achieves this via interactive lessons based on clips from blockbuster movies, hit TV series, and television news reports; chart-topping music videos; professionally produced casual games; visual dictionaries; and a global social network of learners of English. Entertainment Learning was founded by experienced digital entertainment executives Paul Maglione and Frederic Tibout, who launched English Attack! commercially in 2012 after the service had won or been a finalist in several French and European startup competitions including Plugg Brussels, The Next Web Amsterdam, and Seedcamp Paris.
Serious Factory
Seed Round in 2015
Serious Factory is a Paris-based company founded in 2007 that specializes in developing innovative training and sales support simulators. The company's primary offering is the Virtual Training Suite, a Software-as-a-Service solution that enhances traditional learning processes across various industries, including aerospace, automotive, banking, construction, energy, luxury, retail, medical, and telecommunications. Serious Factory leverages expertise in instructional engineering and gamification to create effective training programs that encompass digital learning modules, serious games, blended learning, and practical simulations. Their technology enables businesses to design, distribute, and regularly update educational content while also monitoring skill development. Serious Factory operates through a network of partner resellers across Europe, Asia, and North America.
VitamFero
Series C in 2015
VitamFero SA is a biotechnology company based in Angers, France, that specializes in the development and marketing of prophylactic agents, particularly vaccines and neonatal immunostimulants, aimed at treating various infectious diseases. Founded in 2005, the company utilizes its patented Toxo Mic1-3KO technology to create innovative vaccines targeting Apicomplexe parasites. Its product line includes vaccines such as VFOtx-251 for ovine toxoplasmosis, VFOne-273 for bovine neosporosis, and VFOlh-211 for canine leishmaniasis and equine protozoal myeloencephalitis. With a focus primarily on veterinary healthcare, VitamFero is dedicated to addressing the challenges posed by these infectious agents, thereby improving animal health outcomes.
PayinTech
Seed Round in 2015
PayinTech, founded in 2010 by Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji, specializes in cashless payment solutions utilizing IoT technology. Initially developed for a student bar, the company expanded its offerings to include electronic wristbands and wireless payment terminals, enabling efficient transaction management at large events. Notably, PayinTech powered Europe's first fully cashless festival in 2012, serving 14,000 attendees. With significant funding raised in 2015 and 2017, the company has invested in research and development, allowing it to diversify its services across various private payment markets. PayinTech now operates in 16 countries, providing solutions to resorts, amusement parks, stadiums, and other organizations, enhancing their revenue while improving user experience and optimizing management costs. The company's goal remains to simplify transactional systems for corporate clients in the entertainment and tourism sectors.
Stootie
Seed Round in 2015
Stootie is a mobile classifieds platform that focuses on facilitating peer-to-peer transactions in real time, primarily within local communities. It serves as a convenient tool for users to quickly find and offer various items or services, catering to immediate needs, such as locating a phone charger while at a café. Available on both iOS and Android, Stootie has established itself as a leading app for peer-to-peer services in France. In addition to general classifieds, the platform also offers information, advice, and tips related to living spaces, DIY projects, gardening, and home decoration, making it a versatile resource for users seeking assistance in various areas of everyday life.
Sevenhugs
Seed Round in 2015
Sevenhugs Inc. specializes in ultra-wideband systems for indoor positioning and orientation tracking, providing innovative solutions for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which serves as a universal remote control for televisions and smart home devices. This product simplifies the smart home experience by allowing users to control various devices—such as lights and music—through a single adaptive interface. Additionally, Sevenhugs offers features like secure localization, data fusion, and a low-power MAC protocol, enhancing its capabilities in access and security as well as location tracking. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.
Sevenhugs
Acquisition in 2015
Sevenhugs Inc. specializes in ultra-wideband systems for indoor positioning and orientation tracking, providing innovative solutions for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which serves as a universal remote control for televisions and smart home devices. This product simplifies the smart home experience by allowing users to control various devices—such as lights and music—through a single adaptive interface. Additionally, Sevenhugs offers features like secure localization, data fusion, and a low-power MAC protocol, enhancing its capabilities in access and security as well as location tracking. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.
Open Ocean
Seed Round in 2015
Open Ocean SAS is a company that specializes in developing a SaaS-based decision-making platform focused on managing offshore infrastructure and marine operations. Founded in 2011 and headquartered in Paris and Brest, the company offers a range of products and services, including the Metocean Analytics solution, which analyzes atmospheric and oceanic conditions, and a detailed report on the tidal energy market in France. Additionally, Open Ocean provides a spectral wave database for Scotland, facilitating the development of marine renewable energy. Its services encompass site data analysis, resource and energy assessment, environmental data for design calculations, and research and development for offshore energy projects. Open Ocean caters to farm developers, operators, and public agencies within the renewable marine energy sector, leveraging a highly qualified team of oceanographers skilled in high-resolution modeling and data analysis.
Pherecydes Pharma
Series A in 2014
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, established in 2006. It specializes in the research and development of lytic bacteriophages, which are natural predators of bacteria, for therapeutic and diagnostic applications, particularly in addressing antibiotic resistance. The company has developed several banks of bacteriophages, including a collection targeting Escherichia coli. Pherecydes Pharma is engaged in innovative approaches to personalized phage therapy, aiming to treat bacterial infections by launching multicenter European trials, such as those evaluating phage therapy for infected burn wounds. This therapeutic strategy allows for the detection and treatment of a wide range of bacterial infections, including multi-resistant and emergent strains, without affecting human cells.
Restlet
Convertible Note in 2014
Restlet offers a comprehensive API-First Platform as a Service, enabling developers and non-developers alike to design, document, test, and host APIs efficiently. Its platform facilitates enterprise-level API projects, making cloud, mobile, web, and IoT application development simpler and more secure. Additionally, Restlet maintains the widely-used open-source REST API framework, Restlet Framework, fostering growth in the API development community. Recognized by Gartner as a Cool Vendor in Specialized PaaS in 2015, Restlet is headquartered in San Mateo, California, with an engineering office in Nantes, France.
Web Geo Services
Seed Round in 2014
Web Geo Services SAS, established in 2009 and headquartered in Montpellier, France, specializes in online mapping and location-based applications. The company focuses on providing location SaaS technology for various sectors, including retail, e-commerce, travel, hospitality, banking, insurance, automotive, and mobility. By leveraging Google Maps, Web Geo Services assists businesses in enhancing customer engagement and driving conversions through digital systems that streamline online checkouts and customer journeys. With a client base of over 400 large companies, it has positioned itself as a leading partner of Google Cloud and the foremost Google Maps partner in Europe, with offices in multiple countries. The company has developed Woosmap, an award-winning platform that enables developers to integrate advanced location intelligence features into mobile applications and websites, thereby offering businesses a competitive edge in their respective markets.
Playtem
Venture Round in 2014
Playtem is a video game monetization platform that aims to bridge the gap between gamers and their favorite brands through innovative in-game native advertising formats. The company focuses on creating emotional connections between players and brands, facilitating daily engagement across web and mobile platforms. By prioritizing impactful advertising that enhances user experience, Playtem seeks to revolutionize the future of advertising in the gaming industry. The team, comprised of passionate entrepreneurs, is dedicated to developing solutions that benefit both brands and gamers alike.
Precogs
Seed Round in 2014
Precogs is a company based in Paris, France, founded in 2011, that specializes in business analytics solutions tailored for EMS-ODM-OEM sectors. The company offers a range of services, including supply risk management, enterprise resource planning (ERP), and procurement monitoring. Its key products feature CogWatch, a predictive tool leveraging big data, and Cog Margin, a platform designed for component pricing. Precogs focuses on providing real-time sourcing of electronic components, ensuring that clients receive competitive pricing for their needs.
Rool'in
Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.
Neelogy
Seed Round in 2013
Neelogy SA, established in 2008 and based in Cachan, France, specializes in the development and marketing of advanced electromagnetic sensors. The company focuses on non-remanence magnetic sensors, which are designed for the precise measurement of both alternating and continuous electrical currents. Neelogy's innovative sensors cater to various applications, including energy metering, AC/DC energy conversion, electrical energy storage, and real-time fault detection and diagnostics. By providing space-saving, maintenance-free, and recalibration-free solutions, Neelogy enables clients to achieve accurate measurements of direct current components. As of July 2019, Neelogy operates as a subsidiary of Safran Electrical & Power S.A.S.
Axess Vision Technology
Series B in 2013
Axess Vision Technology S.A. is a French company specializing in the design and production of disposable sterile endoscopes for various medical applications, including bronchoscopy and urology. Founded in 2006 and headquartered in Saint-Pierre-des-Corps, the firm has dedicated significant resources to research and development, culminating in the commercialization of its first single-use endoscope in 2014. With a focus on patient safety and comfort, Axess Vision Technology aims to enhance the efficiency of medical practitioners while addressing emerging health challenges. The company has introduced several innovative products, backed by collaboration with medical experts and a commitment to sustainability and community engagement. Through its ongoing efforts, Axess Vision has secured multiple patents and continues to prioritize innovation in the evolving healthcare landscape.
TISSIUM
Series A in 2013
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.